In the analysis of human tumors, single-cell sequencing data from breast and lung cancers revealed that CD36 is predominantly expressed on TAMs, and that these TAMs have significantly higher expression of CD36 compared with control tissues (87). This evidence concerns the gene CD36 and lung carcinoma.